Lv12
100 积分 2024-03-05 加入
A DXd/TLR7-Agonist Dual-Conjugate Anti-HER2 ADC Exerts Robust Antitumor Activity Through Tumor Cell Killing and Immune Activation
23小时前
已完结
Safety and Efficacy of 68Ga- or 177Lu-Labeled DOTA-IBA as a Novel Theranostic Radiopharmaceutical for Bone Metastases A Phase 0/I Study
27天前
已完结
Safety and Efficacy of 68Ga- or 177Lu-Labeled DOTA-IBA as a Novel Theranostic Radiopharmaceutical for Bone Metastases
27天前
已关闭
Antibody drug conjugate combats inflammation
1个月前
已完结
Chapter 22: The Medicinal Chemistry and Process Chemistry Interface
1个月前
已关闭
Advancements in the development of radiopharmaceuticals for nuclear medicine applications in the treatment of bone metastases
3个月前
已完结
Targeted Radionuclide Therapy of Painful Bone Metastases: Past Developments, Current Status, Recent Advances and Future Directions
3个月前
已完结
What influences the activity of Degrader−Antibody conjugates (DACs)
1年前
已完结
New guise ADCs couple antibodies to degraders
1年前
已完结
皖公网安备34019202002308
